COURT RULING DELAYS MEDICAID CUTS

FEBRUARY 01, 2008

Community pharmacy won an important year-end victory with the US District Court ruling stopping the Centers for Medicare & Medicaid Services (CMS) from implementing its plan to base Medicaid payments for generic prescription drugs on Average Manufacturer Prices (AMPs).

The CMS ruling was scheduled to take effect January 31, resulting in pharmacists receiving payments as much as 36% lower than what certain drugs cost to acquire, according to the Government Accountability Office.

In the lawsuit against the CMS rule filed by the National Community Pharmacists Association and the National Association of Chain Drug Stores, Judge Royce C. Lamberth found there would be "irreparable harm" to community pharmacies.

For more information, visit www.PharmacyTimes.com/AMP.



SHARE THIS SHARE THIS
0

Conference Coverage from ASHP Summer 2017 

Four years after they first launched the Summer Meetings in Minneapolis, Minn., the ASHP 2017 Summer Meetings and Exhibition was in Minneapolis once again.  

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.